• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Nanotechnol . Degradable cyclic amino alcohol ionizable lipids as vectors for potent influenza mRNA vaccines

tetano

Editor, Senior Moderator
Nat Nanotechnol


. 2025 Nov 7.
doi: 10.1038/s41565-025-02044-6. Online ahead of print. Degradable cyclic amino alcohol ionizable lipids as vectors for potent influenza mRNA vaccines

Arnab Rudra[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Akash Gupta[SUP] #[/SUP][SUP] 2 3 [/SUP], Kaelan Reed[SUP] #[/SUP][SUP] 2 3 [/SUP], Amy Deik[SUP] 4 [/SUP], Jiyeon Min[SUP] 5 6 [/SUP], Hasan Mansour A Mansour[SUP] 2 [/SUP], Quang Trung Chinh Nguyen[SUP] 2 [/SUP], Austin Danko[SUP] 2 [/SUP], Yizong Hu[SUP] 2 3 [/SUP], Allegra Berger[SUP] 2 3 [/SUP], Michaela Prado[SUP] 2 7 8 [/SUP], Amira Beck[SUP] 2 3 [/SUP], Clary B Clish[SUP] 4 [/SUP], Jeffery B Klauda[SUP] 5 9 [/SUP], Robert Langer[SUP] 1 2 3 7 8 [/SUP], Daniel G Anderson[SUP] 10 11 12 13 14 [/SUP]



Affiliations
Abstract

The next generation of mRNA vaccines must address several limitations, including enhancing vaccine potency and reducing toxicity. Here we develop a class of degradable, cyclic amino ionizable lipids via sequential combinatorial chemistry and rational design. Lipid nanoparticles (LNPs) formulated with the top-performing ionizable lipid, AMG1541, elicited similar protective neutralization antibody titres against an H3 influenza antigen when compared with the FDA-approved ionizable lipid SM-102 at a 100-fold lower dose, with enhanced clearance in vivo. AMG1541 mRNA LNPs substantially reduced expression in the liver following intramuscular injection, mitigating the associated toxicity. We also observed improved mRNA delivery to antigen-presenting cells at the injection site and the draining lymph node, leading to stronger germinal centre reactions. Structure-activity relationship studies suggest that cyclic headgroups and β-amino alcohols facilitate interactions with the mRNA backbone and enhance endosomal escape. The formulations developed here significantly enhance the potency of mRNA vaccines, and our structural insights may guide the development of next-generation vaccine delivery systems.


 
Back
Top Bottom